» HOME
» INVESTORS
» CAREERS
» ABOUT US
» CONTACT US
» WORLDWIDE
» SITE MAP



Product Information
Clinic Support
Client Information
Technical Information

  
Now that you have an alternative to injectable vaccines, what about one for living with the dog?

» Read More (Acrobat PDF)

A progressive alternative to injectable vaccines.

BENEFITS

  • Provide rapid protection against the most prevalent causes of feline upper respiratory disease (rhinotracheitis virus and calicivirus), plus excellent protection from feline panleukopenia.
  • Safe, effective alternatives to injectable vaccines.
  • Intranasally administered.
  • No needles required to use the vaccines.
  • Eliminate the risk of injection-site sarcomas and reactions.

FEATURES

  • Convenient, easily administered 0.2 mL dose.
  • Rapid local immunity for upper respiratory viruses in 2 – 4 days.
  • Protection with a single mucosal dose.
  • Can be used in kittens 4 weeks of age and older.
  • Intranasal modified-live virus FVRCP vaccine is a type of vaccine recommended by AAFP (American Association of Feline Practitioners) Vaccination Guidelines.

Indications: Recommended for the vaccination of healthy, susceptible cats. Cats can be vaccinated with a single dose at 12 weeks of age. If cats are vaccinated at less than 12 weeks of age, a second vaccination should be administered at 12 - 16 weeks of age. Annual revaccination is recommended. Do not vaccinate pregnant animals.

Integrate one of Heska's product solutions into your practice.

Product Categories


HESKA® Products


» PRODUCT SUPPORT
» PRODUCT MSDS
» PURCHASE OPTIONS
» DISTRIBUTORS


1-800-GO HESKA
©2009 Heska Corporation

Patents and Trademarks
Terms and Conditions